Mismatch repair status influences response to fertility-sparing treatment of endometrial cancer
Patients younger than 40 years usually present with early-stage endometrial cancer with a favorable prognosis. This study aimed to evaluate the prognostic significance of Proactive Molecular Risk. Mismatch repair status could be used as a predictive biomarker for selecting patients who could benefit from hormone therapy.

Related Post